Literature DB >> 27592804

Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

Axel Hauschild1, Dirk Schadendorf2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27592804     DOI： 10.1016/S1470-2045(16)30441-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

1.  Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.

Authors:  Ioannis Gavvovidis; Matthias Leisegang; Gerald Willimsky; Natalie Miller; Paul Nghiem; Thomas Blankenstein
Journal:  Clin Cancer Res       Date:  2018-04-18       Impact factor: 12.531

Review 2.  Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.

Authors:  Shruti Gupta; Frank B Cortazar; Leonardo V Riella; David E Leaf
Journal:  Kidney360       Date:  2020-01-14

3.  Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.

Authors:  Suzanne L Topalian; Shailender Bhatia; Asim Amin; Ragini R Kudchadkar; William H Sharfman; Celeste Lebbé; Jean-Pierre Delord; Lara A Dunn; Michi M Shinohara; Rima Kulikauskas; Christine H Chung; Uwe M Martens; Robert L Ferris; Julie E Stein; Elizabeth L Engle; Lot A Devriese; Christopher D Lao; Junchen Gu; Bin Li; Tian Chen; Adam Barrows; Andrea Horvath; Janis M Taube; Paul Nghiem
Journal:  J Clin Oncol       Date:  2020-04-23       Impact factor: 50.717

Review 4.  A rare case of Merkel cell carcinoma presenting as a giant intra-thoracic mass: A case report and review of the literature.

Authors:  Feng-Wei Kong; Miao Zhang; Heng Wang; Cun-Tao Lu; Wen-Bin Wu; Yuan-Yuan Liu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

5.  Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination.

Authors:  Kerstin F Gerer; Michael Erdmann; Sine R Hadrup; Rikke Lyngaa; Lena-Marie Martin; Reinhard E Voll; Beatrice Schuler-Thurner; Gerold Schuler; Niels Schaft; Stefanie Hoyer; Jan Dörrie
Journal:  Ther Adv Med Oncol       Date:  2017-06-13       Impact factor: 8.168

6.  Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe.

Authors:  Jürgen C Becker; Eva Lorenz; Selma Ugurel; Thomas K Eigentler; Felix Kiecker; Claudia Pföhler; Ivonne Kellner; Friedegund Meier; Katharina Kähler; Peter Mohr; Carola Berking; Gabriele Haas; Christoph Helwig; Dina Oksen; Dirk Schadendorf; Lisa Mahnke; Murtuza Bharmal
Journal:  Oncotarget       Date:  2017-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.